Co-Diffusion: An Affinity-Aware Two-Stage Latent Diffusion Framework for Generalizable Drug-Target Affinity Prediction
Summary
Co-Diffusion is a novel affinity-aware latent diffusion framework designed to improve drug-target affinity (DTA) prediction, especially in challenging cold-start scenarios where data is scarce or exhibits domain shifts. The framework redefines DTA prediction as a constrained latent denoising process, employing a two-stage training paradigm. Stage I establishes an affinity-steered latent manifold by aligning drug and target embeddings using a supervised objective. Stage II then introduces modality-specific latent diffusion as a stochastic perturb-and-denoise regularizer, forcing the model to recover consistent affinity semantics from noisy structural representations. This approach mitigates the common "reconstruction-regression conflict" found in other generative DTA models. Co-Diffusion significantly outperforms state-of-the-art baselines on the KIBA and Davis datasets, demonstrating superior zero-shot generalization on unseen molecular scaffolds and novel protein families, with an 18.5% MSE improvement over PAIR-VAE in out-of-sample PDBbind evaluation.
Key takeaway
Research Scientists developing DTA models should consider adopting Co-Diffusion's two-stage, affinity-aware latent diffusion approach. This framework offers robust generalization in cold-start scenarios by effectively decoupling affinity alignment from generative refinement, thereby overcoming the reconstruction-regression conflict common in other generative models. Implementing this method could lead to more accurate and reliable predictions for novel drug-target pairs, accelerating early-stage drug discovery and virtual screening.
Key insights
Co-Diffusion enhances drug-target affinity prediction in cold-start scenarios using a two-stage, affinity-aware latent diffusion framework.
Principles
- Decouple affinity alignment from generative refinement.
- Latent diffusion regularizes against distribution shifts.
- Maximize variational lower bound for probabilistic coherence.
Method
Co-Diffusion uses a two-stage process: Stage I aligns drug and target embeddings to an affinity-steered latent manifold; Stage II applies modality-specific latent diffusion as a stochastic perturb-and-denoise regularizer to refine affinity semantics.
In practice
- Use GatedConv extractors for sequence feature extraction.
- Employ a 1-D UNet for latent space denoising.
- Optimize diffusion steps (T=1000) and noise magnitude (beta in [1e-4, 4e-4]).
Topics
- Drug-Target Affinity Prediction
- Latent Diffusion Models
- Cold-Start Generalization
- Computational Drug Discovery
- Generative Models
Best for: Research Scientist, AI Researcher, AI Scientist, AI Data Scientist
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by stat.ML updates on arXiv.org.